26-O-acyl isoA beta (1-42) is a modified version of the amyloid beta peptide, where the acyl group enhances membrane permeability and toxicity assessment. The isoA modification stabilizes peptide folding and aggregation tendencies. This variant is employed in research on Alzheimer's disease, focusing on the role of lipid modifications in amyloid plaque formation. Researchers use it to explore aggregation pathways and neurodegenerative processes.
CAT No: A13306
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More